Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 47:1214-1223, doi:10.1016/j.jacc.2006.01.049 (Published online 8 February 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (127)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cribier, A.
Right arrow Articles by Babaliaros, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cribier, A.
Right arrow Articles by Babaliaros, V.

Treatment of Calcific Aortic Stenosis With the Percutaneous Heart Valve

Mid-Term Follow-Up From the Initial Feasibility Studies: The French Experience

Alain Cribier, MD, FACC*,*, Helene Eltchaninoff, MD*, Christophe Tron, MD*, Fabrice Bauer, MD*, Carla Agatiello, MD*, Deborah Nercolini, MD*, Sydney Tapiero, MD*, Pierre-Yves Litzler, MD{dagger}, Jean-Paul Bessou, MD{dagger} and Vasilis Babaliaros, MD*

* Department of Cardiology, Charles Nicolle Hospital, Rouen, France
{dagger} Department of Cardiac Surgery, Charles Nicolle Hospital, Rouen, France


Figure 1
View larger version (88K):

[in a new window]
 
Figure 1 (A) Top view of the percutaneous heart valve in the closed position showing the three pericardial leaflets sutured to the stainless-steel stent. (B) Side view of the percutaneous heart valve crimped over a 3-cm x 22-mm balloon catheter. (C) Side view of the percutaneous heart valve after being expanded by the delivery balloon.

 

Figure 2
View larger version (42K):

[in a new window]
 
Figure 2 Electrocardiogram and aortic pressure curve depicting the effect of rapid stimulation (arrows) of the right ventricle (200 to 220 stimulations/min).

 

Figure 3
View larger version (121K):

[in a new window]
 
Figure 3 (A) Swan-Ganz (SG) catheter is used to direct a guidewire (GW) across the native aortic valve in the antegrade approach. (B) Guidewire loop in the left ventricle is tracked by the percutaneous heart valve from the right femoral vein (antegrade approach). Sones catheter (SC) from the left femoral artery is used to help position the percutaneous heart valve. Native aortic valve calcifications (arrows) in the anteroposterior projection transect the mid-line of the length of the stent valve. (C) Deployment of the percutaneous heart valve using the antegrade approach. (D) Valve deployment via the retrograde method. (E) Supra-aortic angiogram showing no aortic regurgitation and the subcoronary position of the percutaneous heart valve (arrow: filling of the left coronary artery). (F) Cranial view of the percutaneous heart valve showing symmetrical and complete expansion of the stent frame. MS = Mullins sheath; PL = pacing lead.

 

Figure 4
View larger version (27K):

[in a new window]
 
Figure 4 Schematic representation of patient enrollment and procedural success (*Patient #16 was implanted successfully by the antegrade approach after initial retrograde failure). PHV = percutaneous heart valve.

 

Figure 5
View larger version (26K):

[in a new window]
 
Figure 5 (A) Improvements in aortic valve area in patients 24 h, 1, 3, 6, 12, and 24 months after successful implantation. (B) Decrease in mean aortic gradient in patients 24 h, 1, 3, 6, 12, and 24 months after successful implantation.

 

Figure 6
View larger version (28K):

[in a new window]
 
Figure 6 (A) Improvement in ejection fraction one week after successful implantation (n = 22). (B) Improvement in ejection fraction comparing baseline values with values one week after successful implantation in patients with left ventricular function <50% (n = 15).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement